Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Manitoba ranchers taking precautions with livestock during extreme cold

January 23, 2026

Air-dried Food Market Analysis Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

January 23, 2026

Revolutionizing Road Safety: Global Tire Pressure Monitoring System Market to Reach USD 11.38 Billion by 2031

January 23, 2026

Dynamic Machine Perfusion Drives 6.92% CAGR in Organ Preservation Market, Projected to Reach USD 420.06 Million by 2031

January 23, 2026

mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

January 23, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
Press Release

MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

By News RoomJanuary 23, 20266 Mins Read
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
Share
Facebook Twitter LinkedIn Pinterest Email
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on Nasdaq: NASDAQ: MRM, hereinafter “MEDIROM”), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the “MSA”) with Tools for Humanity (“TFH”) and the World Foundation (“WF”), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan.

Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique human, and create a secure and anonymous World ID on their phone.

To promote the nationwide adoption of World ID and deploy Orb authentication terminals across approximately 3,000 locations throughout Japan, we plan to advance nationwide coverage primarily through the following two channels.

1. Expansion within the Re.Ra.Ku Group
Currently, Orbs are installed at more than 150 wellness centres operated by the MEDIROM Group, primarily under the “Re.Ra.Ku” brand.
Going forward, we plan to expand deployment to franchised locations as well, with the aim of installing Orbs at approximately 300 wellness centres across the entire Re.Ra.Ku Group.
Re.Ra.Ku service website: https://reraku.jp/

2. MEDIROM Management Partner Network of Approximately 3,000 Locations
In addition to MEDIROM-operated locations, we plan to collaborate with member stores of the Japan Relaxation Industry Association, as well as other retail and service providers, to expand deployment to approximately 3,000 locations nationwide.
We are currently in negotiations with 370 such third-party locations.

Each partner will participate based on MEDIROM’s standard operating framework, which covers areas such as contracts, branding, privacy protection, and quality control, and will provide authentication services with consistent and standardized quality.

image2.png

■ About Tools for Humanity
Tools for Humanity (TFH) is a global technology company established to build for humans in the age of AI. Founded by Sam Altman and Alex Blania, it led the initial development of World Network and operates World App. Tools for Humanity Corporation is headquartered in San Francisco, California and Munich, Germany. To learn more, visit: toolsforhumanity.com

■ About MEDIROM Group

image3.png

MEDIROM Group operates approximately 300 wellness salons under the “Re.Ra.Ku®” brand nationwide. Since 2015, we have expanded into HealthTech, offering on-demand training apps like Lav® for specific health guidance and lifestyle improvement programs. In 2020, we started manufacturing the 24/7 recharge-free smart tracker “MOTHER Bracelet®,” which is now used in REMONY, our remote monitoring system for various industries including caregiving, transportation, construction, and manufacturing.

About MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Website: https://medirom.co.jp/en
Contact: [email protected]

■ Forward-Looking Statements Regarding MEDIROM
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “designate,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

  • A third party entering into a letter agreement with TFH and WF and the MSA becoming effective;
  • MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives, including the full-scale adoption of World ID and deployment of Orb authentication terminals across 3,000 locations, and achieving its targeted number of verifications;
  • the MSA being early terminated by the World parties for convenience or any other reason;
  • Changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;
  • MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
  • the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;
  • MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
  • MEDIROM’s ability to raise additional capital on acceptable terms or at all;
  • MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;
  • changes in consumer preferences and MEDIROM’s competitive environment;
  • MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
  • the regulatory environment in which MEDIROM operates.

More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/37870c5e-1398-4231-b0c6-2a4fb6182ebc
https://www.globenewswire.com/NewsRoom/AttachmentNg/22bbbbb0-da94-49b6-a2d7-f0b69e54207c
https://www.globenewswire.com/NewsRoom/AttachmentNg/25580cef-5ecf-4437-97e8-ef98e9749c52

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Air-dried Food Market Analysis Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Revolutionizing Road Safety: Global Tire Pressure Monitoring System Market to Reach USD 11.38 Billion by 2031

Dynamic Machine Perfusion Drives 6.92% CAGR in Organ Preservation Market, Projected to Reach USD 420.06 Million by 2031

mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Small Cell Lung Cancer Therapeutics Market Research Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%

Navigating the AI Server Ecosystem: CPU, FPGA, and GPU Architectures Drive Value for Enterprises and Data Centers

Minimalist Furniture Market Analysis Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Rolling Stock Market Analysis Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Editors Picks

Air-dried Food Market Analysis Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

January 23, 2026

Revolutionizing Road Safety: Global Tire Pressure Monitoring System Market to Reach USD 11.38 Billion by 2031

January 23, 2026

Dynamic Machine Perfusion Drives 6.92% CAGR in Organ Preservation Market, Projected to Reach USD 420.06 Million by 2031

January 23, 2026

mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

January 23, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Small Cell Lung Cancer Therapeutics Market Research Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

January 23, 2026

Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%

January 23, 2026

Navigating the AI Server Ecosystem: CPU, FPGA, and GPU Architectures Drive Value for Enterprises and Data Centers

January 23, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version